SlideShare una empresa de Scribd logo
1 de 93
Trials of diet and  lifestyle modification:  Food fights and other battles Lawrence J. Appel, MD, MPH Professor of Medicine, Epidemiology and International Health (Human Nutrition) Johns Hopkins Medical Institutions Sept 2, 2009
Outline ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],Research Settings
 
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Scientific Rationale ,[object Object],[object Object],[object Object]
Magnitude of the BP Problem ,[object Object],[object Object],[object Object],*WHO, World Health Report 2002: Reducing Risks, Promoting Healthy Life, **Kearney Lancet 2005;305:217, ***Vasan, JAMA 2002;287:1003.
Stroke Mortality by Level of Usual Systolic BP* *Source: Prospective Studies Collaboration, Lancet, 2002: Meta-analysis of 61 prospective studies with 2.7m person-yrs, 11.9k deaths  Definition of Hypertension
Blood Pressure Classification  (JNC VII) Category Systolic BP Diastolic BP Normal < 120 and < 80 Pre-hypertension 120-139 or 80–89 Hypertension Stage 1 Stage 2 140–159 > 160 or or 90–99 > 100
Distribution of BP Levels in US Adults, Ages 18 and Older (NHANESIII) “ Normal” <120/80 Prehypertension SBP 120-39 or DBP 80-89 Hypertension SBP  >  140 or DBP  >   90 Source:  Wang, Hypertension, 2004 42% 27% 31%
Prevalence of High Blood Pressure by Age and Race/Ethnicity, Women, Age 18 and Older * Extimate is based on sample size not meeting requirement of NHANES III design or relative standard error is greater than 30 percent. 100 30 20 10 0 Percent 40 Black  (excludes Hispanic Blacks) 80 70 60 50 90 White  (excludes Hispanic Whites) Mexican American 18-29 2.0* 1.0* 0.6* 30-39 11.3 6.2 4.6* 40-49 30.5 10.6 12.7 50-59 47.9 33.5 36.8 60-69 77.8 59.3 50.9 70-79 72.6 67.0 66.9 80 + 80.5* 71.0* 74.3 Source:  Burt V, et al.  Hypertension, 1995
Mean SBP and DBP by Age and Race/Ethnicity for Women, Age 18 Years and Older 150 140 130 120 110 100 90 80 70 mm Hg 18-29 30-39 40-49 50-59 60-69 70-79 80+ Diastolic Systolic Source:  Burt V, et al.  Hypertension, 1995 SBP Rise with Age = ~0.6 mmHg per year Age Black White Mexican-American
Roles of Non-Pharmacologic (“Lifestyle”) Therapies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Effects of Population-Based BP Reduction (Shifting SBP Distribution Downward)   Stamler R.  Hypertension 1991;17:I-16–I-20. % Reduction in Mortality  Reduction in BP After Intervention Before Intervention Stroke CHD Total -6 -4 -3 -8 -5 -4 -14 -9 -7 Reduction in SBP mmHg 2 3 5
Completed Trials
Types of Trials Type of Trial Research Question Examples Feeding Studies Effects of Diet Change on Blood Pressure and Other Risk Factors DASH DASH-Na OmniHeart Behavioral Intervention Studies Feasibility and Effects of Lifestyle Change in Free-Living Individuals TOHP1 TOHP2 TONE PREMIER Wt Loss Maintenance
D ietary A pproaches to S top H ypertension
DASH Centers Hopkins Pennington Brigham NHLBI Duke CHR
Objective ,[object Object]
Run-in and Intervention Periods 3 wks 8 weeks Run-in Intervention Control Diet Control F & V Combination Randomization
Feeding Protocol ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Baseline Characteristics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The DASH Diet ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The DASH diet
Weekly BP by Diet During Intervention Feeding WEEKS B  1 2 3  4   5   6   7,8 DIASTOLIC SYSTOLIC Appel, NEJM 1997;336:1117
Effect of DASH Diet  by BP Status  Hypertensives Non-Hypertensives * † *  * * * p< 0.05 (main effect) †  p< 0.05 (BP status interaction)
The DASH diet:  Can it be improved?
Objective ,[object Object],[object Object],[object Object],[object Object]
Participant Flow Period 1 6 weeks Period 2 6 weeks Period 3 6 weeks Randomization to 1 of 6 sequences Washout Period 2–4 wk Washout Period 2-4 wk BP, Lipids: Run-In 6 days Participants Ate Study Food Screening / Baseline Participants Ate Their Own Food
Macronutrient Goals, % kcal *Similar to DASH diet.  All diets were healthy: cholesterol 150 mg/d, fiber 30 g/d, sodium 100 mmol/d, potassium 120 mmol/d, magnesium 500 mg/d, calcium 1,200 mg/d CARB* Carbohydrate 58 Protein 15 Fat 27 Monounsaturated 13 Polyunsaturated 8 Saturated 6
Macronutrient Goals, % kcal *Similar to DASH diet.  All diets were healthy: cholesterol 150 mg/d, fiber 30 g/d, sodium 100 mmol/d, potassium 120 mmol/d, magnesium 500 mg/d, calcium 1,200 mg/d CARB* PROT Carbohydrate 58 48 Protein 15 25 Fat 27 27 Monounsaturated 13 13 Polyunsaturated 8 8 Saturated 6 6
Macronutrient Goals, % kcal *Similar to DASH diet.  All diets were healthy: cholesterol 150 mg/d, fiber 30 g/d, sodium 100 mmol/d, potassium 120 mmol/d, magnesium 500 mg/d, calcium 1,200 mg/d CARB* PROT UNSAT Carbohydrate 58 48 48 Protein 15 25 15 Fat 27 27 37 Monounsaturated 13 13 21 Polyunsaturated 8 8 10 Saturated 6 6 6
Systolic Blood Pressure   CARB*  PROT  UNSAT  CARB*  PROT  UNSAT All (n = 164) Baseline mean =   131.2 mmHg Hypertension (n = 32)   Baseline mean = 146.5 mmHg p = 0.002 -1.4 -1.3 p = 0.005 -2.9 p = 0.02 -3.5 p = 0.006 * CARB  similar to   DASH diet Appel, JAMA 2005;294:2455
LDL Cholesterol   CARB*  PROT  UNSAT  CARB*  PROT  UNSAT All (n = 161) Baseline mean =   129.2 mg/dL LDL  ≥ 130 mg/dL  (n = 75)   Baseline mean = 156.7 mg/dL p = 0.01 -3.3 +1.5 p = 0.24 -1.5 p = 0.22 -2.1 p = 0.33 +1.7 p = 0.45 -3.9 p = 0.09 * CARB  similar to   DASH diet
Effects of Reducing (Substituting) Carbohydate on BP in Hypertensives 1 He, Ann Int Med, 2005;  2 Appel, JAMA, 2005;  3 Hodgson, AJCN, 2006 Partially Substituting Carbohydrate with: Carb (% kcal) Reduction Net SBP Net DBP Soy Protein 1 -3.7% -7.9 -5.3 Mixed Protein 2 -10% -3.5 -2.4 Lean Red Meat 3 -5.3% -5.2 +0.2 Monounsat Fat 2 -10% -2.9 -1.9
Salt Matters
Key Studies Supporting the Role of Sodium Reduction as a Means to Lower BP Non-Hypertensives Study  Reduce BP DASH-Na Prevent hypertension TOHP 2 Prevent age-related rise in  BP INTERSALT Prevent CVD events TOHP 3 Hypertensives Initial therapy DASH-Na Adjunct to drug therapy TONE Substitute for medication TONE
Incident Hypertension in TOHP2
Percent Reduction in Incident Hypertension over 36-48 Months from Weight Loss and Sodium Reduction Interventions in TOHP2 6 Months 18 Months End of Study * * * * * * * * *  P <0.05
Control Diet Randomization Run-in: (11-14 days) Intervention  (Three 30-day periods, random order)  Intermediate  Sodium Higher   Sodium Lower   Sodium Higher  Sodium Intermediate  Sodium Lower   Sodium Study Design Control Diet,  N = 204 DASH Diet,  N = 208 N = 412
Effect of  Sodium Level  on  Systolic Blood Pressure Systolic Blood  Pressure Control Diet DASH Diet Higher  Intermed   Lower Sodium Level (mmol/d) - 6.7 p<.0001 - 3.0 P<.0001 Sacks, NEJM 2001;344:3 (143)  (106)  (65) - 2.1 - 1.3 - 1.7 - 4.6
Systolic Blood  Pressure Control Diet DASH Diet Higher  Intermed  Lower Sodium Level Effect of  DASH Diet  on  Systolic Blood Pressure -2.2 p=.02 -5.0 p=.0003 -5.9 p<0.0001
Interactive Effects of Reduced Na and DASH Diet on Systolic BP Systolic Blood  Pressure Higher    Lower Sodium Level Na Effect in Control Diet = - 6.7 DASH Effect  - 5.7 Combined* Effects   Actual = - 8.9 Predicted  = - 12.4 * P < 0.001, Strict Additivity
Effects of Reduced Na on CVD Events:  Results from 3 Randomized Trials INTERVENTION OUTCOME FU TONE (2001) 639 Elderly ↓  Na 21% ↓ CVD events 2.3 yrs Taiwan Veterans (2006) 1,981 Elderly ↓  Na /↑ K Salt 41%* ↓ CVD Mortality 2.6 yrs TOHP Follow-up [abs] 3,126 Prehypertensives ↓  Na 30%* ↓ CVD events 10-15 yrs *p<0.05
Effects of Reduced Na Intake on CVD:  Longterm Results from the Trials of Hypertension Prevention (Cook et al, BMJ, 2007) Adj RR = 0.70 p=0.02
Opportunities to Reduce Racial Disparities in BP
Effect of Na Reduction (Higher to Lower) in African-Americans and Non-African-Americans on Typical American Diet African-Americans Non-African-Americans - 8.0 † P<.001 - 4.5 † P<.001 - 5.1 P<.001 - 2.2 P<.001 0  †  P-interaction < 0.05
Effect of DASH  Diet By Race African-Americans Non-African-Americans * † *  * * * p< 0.05 (main effect) †  p< 0.05 (race interaction)
Older-aged individuals can make and sustain lifestyle changes that control BP
Mean Change in Weight (kg) by Randomized Group in Older-Aged Persons (TONE) 0  9  18  30 Whelton JAMA 1998;279:839.
Mean Change in Urinary Sodium Excretion (mmol/24hr) in Older-Aged Persons (TONE) 0  9  18  30 Whelton JAMA 1998;279:839.
[object Object],Appel, JAMA 2003;289:2083
Design Randomization Primary Outcomes (6 months) End of Intervention (18 months) = Data Visit ADVICE ONLY EST EST + DASH
Change in Weight (kg)  (Baseline Wt = 97 kg) * * *p<0.001 vs Advice Change in Wt (Kg)
Change in Fitness*  (Baseline = 130 beats/min) * *p<0.05 vs Advice Change in HR (Beats/min) * Heart Rate (beats/min at Stage 2 of exercise test)
Change in Urine Na Excretion  (Baseline=170 mmol/24 hr) * * * p < 0.05 vs Advice Change in Urine Na (mmol/24 hr)
Fruit and Vegetable Intake (servings/day) *  p <.001  EST+ DASH vs Advice + p <.001 EST + DASH vs EST * + Fruit and Veg (serv/day)
Saturated Fat Intake (% kcal) **  p <.05 vs Advice *  p <.0001 vs Advice +  p <.0001 EST+DASH vs  EST * + ** Sat Fat Intake (%kcal)
Hypertension Prevalence (Among Those with Hypertension at Baseline) + p <.01  vs Advice % with Hypertension + + + +
10-Year Probability of CHD Event RR = 0.89 (0.84-0.94),  P  <0.001 RR = 0.87 (0.82-0.92),  P  <0.001
2005 Dietary Guidelines for Americans JNC VII – Hypertension Prevention and Treatment Guidelines 2006 American Heart Association Guidelines
Ongoing Trials
P ractice-Based  O pportunities for  We ight  R eduction (POWER) Trial ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Design Self-Directed (SD) – comparison group Call-Center Directed (CCD) In-Person Directed (IPD) Randomization Last visits: 24 – 36 m after randomization = Data Collection Points, every 6 months during follow-up
Description of Groups Randomized Groups Self-Directed (SD) Call-Center Directed (CCD) In-Person Directed (IPD) Counselor: None Healthways Coach Hopkins  Coach Static Website: √ Interactive Web-site: √ √ Sessions: Telephone Only Group Mtgs Individual  Telephone PCP Reinforcement √ √
CCD and IPD Intervention Goals Weight Goal Minimum 5% weight loss, individually tailored  Behaviors Calories 1200 kcal/d if ≤ 170 lb; 1500 kcal/d if > 170 lb and < 220 lb; 1800 kcal/d if  >  220 lb and < 270 lb; 2200 kcal/d if  >  270 lb  Diet DASH diet 7-12 services of fruits/vegetables 2-3 servings of low fat dairy low sodium ≤  25% of calories from fat Exercise Build to ≥ 180 minutes/wk of moderate intensity physical activity in bouts ≥ 10 minutes in length
Novel Intervention Website ,[object Object],[object Object],[object Object],Intervention Website Coach Physician Patient
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],O ptimal  M acro n utrient  I ntake for  Carb ohydrate
[object Object],[object Object],[object Object],Glycemic Index (GI)  High GI (>65)  Low GI (<45) High Carb (58% Kcal) Low Carb (40% kcal)
Lessons and Battles (Food Fights)
Lesson 1 ,[object Object],[object Object],[object Object]
Lesson 2 ,[object Object],[object Object],[object Object],[object Object]
Lesson 3 ,[object Object],[object Object],[object Object]
Lesson 4 ,[object Object]
Obstacle 1: Design ,[object Object],[object Object],[object Object],[object Object]
Obstacle 2: Logistics ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Battle 1: Funding ,[object Object],[object Object],[object Object],[object Object],[object Object]
Costs of Lifestyle  Intervention Trials Sample Size Duration of Intervention Total Costs Per Participant Costs POWER 415 2 yr $5.9 m $14.2k
Costs of Feeding Studies Sample Size Duration of Feeding Total Costs Per Participant Costs DASH 459 11wk $7.8 m $17k DASH-Sodium 412 14 wk $11.8 m $29k Omni Heart 160 19 wk $6.2 m $39k Omni Carb  160 21 wk $10.3 m $64k
Costs of Mass Mailing in Feeding Studies DASH DASH-Sodium OmniHeart # Brochures Sent 115,000 265,000 393,000 # Enrolled from Mass Mailing 90 69 72 Yield/ 10k Brochures 7.8 2.6 1.8 Mailing Costs Per Enrolled $486 $1,459 $2,074 Total Mailing Costs $43,700 $100,700 $149,340
Pre-Approval Process ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Battle 2: Vested Interests ,[object Object],[object Object],[object Object],[object Object]
 
 
 
 
 
Battle 3: Interpretation  and Policy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],“ B ” Categories of Evidence Linking Reduced Salt Intake to Fewer ASCVD Events   Categories of Evidence: A=Extensive Trial, B=Limited Trial, C=Observational Studies, D=Consensus of Experts
MI, CHD Death, or Revascularization (all participants) Stroke Effects of WHI Dietary Modification Intervention on Total CVD and Stroke Time, y HR, 0.97 (95% CI, 0.90-1.06) Comparison Intervention Time, y HR,1.02 (95% CI, 0.90-1.15) Comparison Intervention
Comparison of Lipids, Blood Pressure, and Framingham Risk Score Effects of WHI Diet and OMNI-Heart* Diets *OMNI-Heart = Optimal Macronutrient Intake Trial to Prevent Heart Disease Source:  Appel LJ, et al.  JAMA  2005; 294:2455-64   OMNI-Heart WHI Carb Protein Unsat Fat (yr 3) Total Chol (mg/dl) -3.3 -12.4 -19.9 -15.4 LDL-C -3.6 -11.6 -14.2 -13.1 HDL-C -0.4 -1.4 -2.6 -0.3 Triglycerides 0 0.1 -16.4 -9.3 SBP (mmHg) -0.2 -8.2 -9.5 -9.3 DBP (mmHg) -0.3 -4.1 -5.2 -4.8 Framingham    Estimated 10-Yr Risk  3-4%  16%  21%  20%
Summary ,[object Object],[object Object],[object Object]
Final Lesson ,[object Object]

Más contenido relacionado

La actualidad más candente

Dyslipidemia in diabetes
Dyslipidemia in diabetesDyslipidemia in diabetes
Dyslipidemia in diabetesMohsen Eledrisi
 
Dyslipidemia 'from guidelines to practice' prof.alaa wafaa
Dyslipidemia 'from guidelines to practice' prof.alaa wafaaDyslipidemia 'from guidelines to practice' prof.alaa wafaa
Dyslipidemia 'from guidelines to practice' prof.alaa wafaaalaa wafa
 
Management of dyslipidemia
Management of dyslipidemiaManagement of dyslipidemia
Management of dyslipidemiaMohsen Eledrisi
 
Nutrition and Hemodialysis
Nutrition and HemodialysisNutrition and Hemodialysis
Nutrition and HemodialysisMNDU net
 
Revise Family Case Presentation Final
Revise Family Case Presentation   FinalRevise Family Case Presentation   Final
Revise Family Case Presentation Finalliza mariposque
 
Nutrition therapy work shop dawly second part 2017
Nutrition therapy work shop dawly   second part  2017Nutrition therapy work shop dawly   second part  2017
Nutrition therapy work shop dawly second part 2017FarragBahbah
 
Diabetic dyslipidemia
Diabetic dyslipidemiaDiabetic dyslipidemia
Diabetic dyslipidemiaFarragBahbah
 
Nutrition in ckd &amp; hd dawly 2017
Nutrition in ckd &amp; hd  dawly 2017Nutrition in ckd &amp; hd  dawly 2017
Nutrition in ckd &amp; hd dawly 2017FarragBahbah
 
Management of dyslipidemia 2019 update
Management of dyslipidemia  2019 update Management of dyslipidemia  2019 update
Management of dyslipidemia 2019 update Moustafa Mokarrab
 
Diabetes and Cardiovascular Disease
Diabetes and Cardiovascular DiseaseDiabetes and Cardiovascular Disease
Diabetes and Cardiovascular DiseaseMashfiqul Hasan
 
Nutrition of patients undergoing dialysis
Nutrition of patients undergoing dialysisNutrition of patients undergoing dialysis
Nutrition of patients undergoing dialysisManiz Joshi
 
Atorvastatin:  Statins in CVD management. Is just lipid lowering enough
Atorvastatin:  Statins in CVD management.  Is just lipid lowering enough Atorvastatin:  Statins in CVD management.  Is just lipid lowering enough
Atorvastatin:  Statins in CVD management. Is just lipid lowering enough Dr Vivek Baliga
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementPraveen Nagula
 
Trajectories of lipids profile and incident cvd risk
Trajectories of lipids profile and incident cvd riskTrajectories of lipids profile and incident cvd risk
Trajectories of lipids profile and incident cvd riskPraveen Nagula
 
Indian lipid guideline 2016 dibu final
Indian lipid guideline 2016 dibu final Indian lipid guideline 2016 dibu final
Indian lipid guideline 2016 dibu final dibufolio
 
Dyslipdemia and Rosuvastatin by prof taj jamshaid
Dyslipdemia and Rosuvastatin by prof taj jamshaidDyslipdemia and Rosuvastatin by prof taj jamshaid
Dyslipdemia and Rosuvastatin by prof taj jamshaidTAJ JAMSHAD
 

La actualidad más candente (20)

Dyslipidemia in diabetes
Dyslipidemia in diabetesDyslipidemia in diabetes
Dyslipidemia in diabetes
 
CASE STUDY ON DIABETES
CASE STUDY ON DIABETES CASE STUDY ON DIABETES
CASE STUDY ON DIABETES
 
Dyslipidemia 'from guidelines to practice' prof.alaa wafaa
Dyslipidemia 'from guidelines to practice' prof.alaa wafaaDyslipidemia 'from guidelines to practice' prof.alaa wafaa
Dyslipidemia 'from guidelines to practice' prof.alaa wafaa
 
Management of dyslipidemia
Management of dyslipidemiaManagement of dyslipidemia
Management of dyslipidemia
 
Nutrition and Hemodialysis
Nutrition and HemodialysisNutrition and Hemodialysis
Nutrition and Hemodialysis
 
Revise Family Case Presentation Final
Revise Family Case Presentation   FinalRevise Family Case Presentation   Final
Revise Family Case Presentation Final
 
Nutrition therapy work shop dawly second part 2017
Nutrition therapy work shop dawly   second part  2017Nutrition therapy work shop dawly   second part  2017
Nutrition therapy work shop dawly second part 2017
 
Diet in ckd
Diet in ckdDiet in ckd
Diet in ckd
 
Diabetic dyslipidemia
Diabetic dyslipidemiaDiabetic dyslipidemia
Diabetic dyslipidemia
 
Nutrition in ckd &amp; hd dawly 2017
Nutrition in ckd &amp; hd  dawly 2017Nutrition in ckd &amp; hd  dawly 2017
Nutrition in ckd &amp; hd dawly 2017
 
Management of dyslipidemia 2019 update
Management of dyslipidemia  2019 update Management of dyslipidemia  2019 update
Management of dyslipidemia 2019 update
 
Diabetes and Cardiovascular Disease
Diabetes and Cardiovascular DiseaseDiabetes and Cardiovascular Disease
Diabetes and Cardiovascular Disease
 
Nutrition of patients undergoing dialysis
Nutrition of patients undergoing dialysisNutrition of patients undergoing dialysis
Nutrition of patients undergoing dialysis
 
Nutrition in Peritoneal Dialysis
Nutrition in Peritoneal DialysisNutrition in Peritoneal Dialysis
Nutrition in Peritoneal Dialysis
 
Atorvastatin:  Statins in CVD management. Is just lipid lowering enough
Atorvastatin:  Statins in CVD management.  Is just lipid lowering enough Atorvastatin:  Statins in CVD management.  Is just lipid lowering enough
Atorvastatin:  Statins in CVD management. Is just lipid lowering enough
 
SGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes managementSGLT2I The paradigm change in diabetes management
SGLT2I The paradigm change in diabetes management
 
Trajectories of lipids profile and incident cvd risk
Trajectories of lipids profile and incident cvd riskTrajectories of lipids profile and incident cvd risk
Trajectories of lipids profile and incident cvd risk
 
Dkd new look
Dkd new lookDkd new look
Dkd new look
 
Indian lipid guideline 2016 dibu final
Indian lipid guideline 2016 dibu final Indian lipid guideline 2016 dibu final
Indian lipid guideline 2016 dibu final
 
Dyslipdemia and Rosuvastatin by prof taj jamshaid
Dyslipdemia and Rosuvastatin by prof taj jamshaidDyslipdemia and Rosuvastatin by prof taj jamshaid
Dyslipdemia and Rosuvastatin by prof taj jamshaid
 

Destacado

Prezentation \" OS Windiws\"
Prezentation \" OS Windiws\"Prezentation \" OS Windiws\"
Prezentation \" OS Windiws\"KristG
 
Ddd part 2 modelling qiscus
Ddd part 2   modelling qiscusDdd part 2   modelling qiscus
Ddd part 2 modelling qiscusHiraq Citra M
 
A FEW SAMPLE SLIDES
A FEW SAMPLE SLIDESA FEW SAMPLE SLIDES
A FEW SAMPLE SLIDESLenni
 
Guide for de mystifying law of trade mark litigation in India
Guide for de mystifying law of trade mark litigation in IndiaGuide for de mystifying law of trade mark litigation in India
Guide for de mystifying law of trade mark litigation in IndiaVijay Dalmia
 
20 начина да си убиеш блога, без да се усетиш
20 начина да си убиеш блога, без да се усетиш20 начина да си убиеш блога, без да се усетиш
20 начина да си убиеш блога, без да се усетишVeselin Nikolov
 
IPR Enforcement in India through Criminal Measures - By Vijay Pal Dalmia
IPR Enforcement in India through Criminal Measures - By Vijay Pal DalmiaIPR Enforcement in India through Criminal Measures - By Vijay Pal Dalmia
IPR Enforcement in India through Criminal Measures - By Vijay Pal DalmiaVijay Dalmia
 
IDP Asia Brochure
IDP Asia BrochureIDP Asia Brochure
IDP Asia Brochureguest0a024
 
Pertemuan Struktural Desember 2008 Baru
Pertemuan Struktural Desember 2008 BaruPertemuan Struktural Desember 2008 Baru
Pertemuan Struktural Desember 2008 Barupuskesmas mojoagung
 
Saint valentine’s story
Saint valentine’s storySaint valentine’s story
Saint valentine’s storyanacarietta
 
Determining Your Community's Competitive Advantage For The Creative Sector
Determining Your Community's Competitive Advantage For The Creative SectorDetermining Your Community's Competitive Advantage For The Creative Sector
Determining Your Community's Competitive Advantage For The Creative SectorEmily Robson
 
Selected Aspects of Software Development
Selected Aspects of Software DevelopmentSelected Aspects of Software Development
Selected Aspects of Software DevelopmentHaitham El-Ghareeb
 
Ip It Laws Newsletter October 2010 Vaish Associates India
Ip It Laws Newsletter October 2010 Vaish Associates IndiaIp It Laws Newsletter October 2010 Vaish Associates India
Ip It Laws Newsletter October 2010 Vaish Associates IndiaVijay Dalmia
 
Shn Overview Updated 2009 06 P31 36
Shn Overview   Updated 2009 06 P31 36Shn Overview   Updated 2009 06 P31 36
Shn Overview Updated 2009 06 P31 36joaovox
 
Сигурност при разработката на WordPress разширения
Сигурност при разработката на WordPress разширенияСигурност при разработката на WordPress разширения
Сигурност при разработката на WordPress разширенияVeselin Nikolov
 
Law Of Industrial Patent Design In India by Vijay Dalmia
Law Of Industrial Patent Design In India by Vijay DalmiaLaw Of Industrial Patent Design In India by Vijay Dalmia
Law Of Industrial Patent Design In India by Vijay DalmiaVijay Dalmia
 
Law of Tele-medicine in India
Law of Tele-medicine in IndiaLaw of Tele-medicine in India
Law of Tele-medicine in IndiaVijay Dalmia
 

Destacado (20)

Native Floridians
Native FloridiansNative Floridians
Native Floridians
 
Prezentation \" OS Windiws\"
Prezentation \" OS Windiws\"Prezentation \" OS Windiws\"
Prezentation \" OS Windiws\"
 
Ddd part 2 modelling qiscus
Ddd part 2   modelling qiscusDdd part 2   modelling qiscus
Ddd part 2 modelling qiscus
 
Milieu
MilieuMilieu
Milieu
 
A FEW SAMPLE SLIDES
A FEW SAMPLE SLIDESA FEW SAMPLE SLIDES
A FEW SAMPLE SLIDES
 
Guide for de mystifying law of trade mark litigation in India
Guide for de mystifying law of trade mark litigation in IndiaGuide for de mystifying law of trade mark litigation in India
Guide for de mystifying law of trade mark litigation in India
 
20 начина да си убиеш блога, без да се усетиш
20 начина да си убиеш блога, без да се усетиш20 начина да си убиеш блога, без да се усетиш
20 начина да си убиеш блога, без да се усетиш
 
IPR Enforcement in India through Criminal Measures - By Vijay Pal Dalmia
IPR Enforcement in India through Criminal Measures - By Vijay Pal DalmiaIPR Enforcement in India through Criminal Measures - By Vijay Pal Dalmia
IPR Enforcement in India through Criminal Measures - By Vijay Pal Dalmia
 
IDP Asia Brochure
IDP Asia BrochureIDP Asia Brochure
IDP Asia Brochure
 
Pertemuan Struktural Desember 2008 Baru
Pertemuan Struktural Desember 2008 BaruPertemuan Struktural Desember 2008 Baru
Pertemuan Struktural Desember 2008 Baru
 
Saint valentine’s story
Saint valentine’s storySaint valentine’s story
Saint valentine’s story
 
Determining Your Community's Competitive Advantage For The Creative Sector
Determining Your Community's Competitive Advantage For The Creative SectorDetermining Your Community's Competitive Advantage For The Creative Sector
Determining Your Community's Competitive Advantage For The Creative Sector
 
Selected Aspects of Software Development
Selected Aspects of Software DevelopmentSelected Aspects of Software Development
Selected Aspects of Software Development
 
Gr8 6 3 Str
Gr8 6 3 StrGr8 6 3 Str
Gr8 6 3 Str
 
Ip It Laws Newsletter October 2010 Vaish Associates India
Ip It Laws Newsletter October 2010 Vaish Associates IndiaIp It Laws Newsletter October 2010 Vaish Associates India
Ip It Laws Newsletter October 2010 Vaish Associates India
 
Shn Overview Updated 2009 06 P31 36
Shn Overview   Updated 2009 06 P31 36Shn Overview   Updated 2009 06 P31 36
Shn Overview Updated 2009 06 P31 36
 
Сигурност при разработката на WordPress разширения
Сигурност при разработката на WordPress разширенияСигурност при разработката на WordPress разширения
Сигурност при разработката на WordPress разширения
 
Law Of Industrial Patent Design In India by Vijay Dalmia
Law Of Industrial Patent Design In India by Vijay DalmiaLaw Of Industrial Patent Design In India by Vijay Dalmia
Law Of Industrial Patent Design In India by Vijay Dalmia
 
Nice to meet you
Nice to meet youNice to meet you
Nice to meet you
 
Law of Tele-medicine in India
Law of Tele-medicine in IndiaLaw of Tele-medicine in India
Law of Tele-medicine in India
 

Similar a Trials of diet and lifestyle modifications: Food fights and other battles

The Health Effects of Reducing Sodium and Improving Overall Diet
The Health Effects of Reducing Sodium and Improving Overall DietThe Health Effects of Reducing Sodium and Improving Overall Diet
The Health Effects of Reducing Sodium and Improving Overall DietNational Restaurant Association
 
Salt and Cardiovascular Mortality
Salt and Cardiovascular MortalitySalt and Cardiovascular Mortality
Salt and Cardiovascular MortalityRichard Hanneman
 
AH and physical activity (1).pptx
AH and physical activity (1).pptxAH and physical activity (1).pptx
AH and physical activity (1).pptxnithishkumar184
 
Role of aci ccb in htn management
Role of aci ccb in htn managementRole of aci ccb in htn management
Role of aci ccb in htn managementDr. Adel El Naggar
 
Hypertension non pharmcolical management
Hypertension   non pharmcolical managementHypertension   non pharmcolical management
Hypertension non pharmcolical managementUniversity of Florida
 
Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension Toufiqur Rahman
 
Update in hypertension management
Update in hypertension managementUpdate in hypertension management
Update in hypertension managementTarek Khalil
 
IMOGEN HALL UROP POSTER FINAL
IMOGEN HALL UROP POSTER FINALIMOGEN HALL UROP POSTER FINAL
IMOGEN HALL UROP POSTER FINALImogen Hall
 
Blood pressure control in diabetes
Blood pressure control in diabetesBlood pressure control in diabetes
Blood pressure control in diabetesBALASUBRAMANIAM IYER
 
Low carb diets and heart & kidneys
Low carb diets and heart & kidneys Low carb diets and heart & kidneys
Low carb diets and heart & kidneys Reijo Laatikainen
 

Similar a Trials of diet and lifestyle modifications: Food fights and other battles (20)

The Health Effects of Reducing Sodium and Improving Overall Diet
The Health Effects of Reducing Sodium and Improving Overall DietThe Health Effects of Reducing Sodium and Improving Overall Diet
The Health Effects of Reducing Sodium and Improving Overall Diet
 
Salt and Cardiovascular Mortality
Salt and Cardiovascular MortalitySalt and Cardiovascular Mortality
Salt and Cardiovascular Mortality
 
Hypertension
HypertensionHypertension
Hypertension
 
AH and physical activity (1).pptx
AH and physical activity (1).pptxAH and physical activity (1).pptx
AH and physical activity (1).pptx
 
Telmisartan combination uses
Telmisartan combination usesTelmisartan combination uses
Telmisartan combination uses
 
Role of aci ccb in htn management
Role of aci ccb in htn managementRole of aci ccb in htn management
Role of aci ccb in htn management
 
Hypertension non pharmcolical management
Hypertension   non pharmcolical managementHypertension   non pharmcolical management
Hypertension non pharmcolical management
 
Hipertensi
HipertensiHipertensi
Hipertensi
 
Htn & Diabetes1
Htn & Diabetes1Htn & Diabetes1
Htn & Diabetes1
 
New dash
New dashNew dash
New dash
 
Management of Hypertension
 Management of Hypertension Management of Hypertension
Management of Hypertension
 
PREVENTION OF TYPE 2 DIABETES
  PREVENTION OF TYPE 2 DIABETES  PREVENTION OF TYPE 2 DIABETES
PREVENTION OF TYPE 2 DIABETES
 
Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension Epidemiology , diagnosis and treatment of Hypertension
Epidemiology , diagnosis and treatment of Hypertension
 
Hypertension & Diabetes
Hypertension & DiabetesHypertension & Diabetes
Hypertension & Diabetes
 
Update in hypertension management
Update in hypertension managementUpdate in hypertension management
Update in hypertension management
 
IMOGEN HALL UROP POSTER FINAL
IMOGEN HALL UROP POSTER FINALIMOGEN HALL UROP POSTER FINAL
IMOGEN HALL UROP POSTER FINAL
 
Hypertension
HypertensionHypertension
Hypertension
 
Blood pressure control in diabetes
Blood pressure control in diabetesBlood pressure control in diabetes
Blood pressure control in diabetes
 
Low carb diets and heart & kidneys
Low carb diets and heart & kidneys Low carb diets and heart & kidneys
Low carb diets and heart & kidneys
 
Lchf cvd
Lchf cvdLchf cvd
Lchf cvd
 

Más de US Cochrane Center

Más de US Cochrane Center (6)

Maureen Maguire April 1 2009
Maureen Maguire April 1 2009Maureen Maguire April 1 2009
Maureen Maguire April 1 2009
 
Doug Altman 15 Jan09 V4
Doug Altman 15 Jan09 V4Doug Altman 15 Jan09 V4
Doug Altman 15 Jan09 V4
 
Komatsoulis Jhu
Komatsoulis JhuKomatsoulis Jhu
Komatsoulis Jhu
 
Peter Keating Dec2008
Peter Keating Dec2008Peter Keating Dec2008
Peter Keating Dec2008
 
Challenges in Clinical Trials Networks
Challenges in Clinical Trials NetworksChallenges in Clinical Trials Networks
Challenges in Clinical Trials Networks
 
Imp Act Presentation
Imp Act PresentationImp Act Presentation
Imp Act Presentation
 

Último

Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxMaryGraceBautista27
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfTechSoup
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Celine George
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxHumphrey A Beña
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomnelietumpap1
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatYousafMalik24
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxDr.Ibrahim Hassaan
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPCeline George
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptxSherlyMaeNeri
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...Postal Advocate Inc.
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSJoshuaGantuangco2
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxAshokKarra1
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designMIPLM
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPCeline George
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfphamnguyenenglishnb
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfMr Bounab Samir
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYKayeClaireEstoconing
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONHumphrey A Beña
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Celine George
 

Último (20)

Science 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptxScience 7 Quarter 4 Module 2: Natural Resources.pptx
Science 7 Quarter 4 Module 2: Natural Resources.pptx
 
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdfInclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
Inclusivity Essentials_ Creating Accessible Websites for Nonprofits .pdf
 
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
Incoming and Outgoing Shipments in 3 STEPS Using Odoo 17
 
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptxINTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
INTRODUCTION TO CATHOLIC CHRISTOLOGY.pptx
 
ENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choomENGLISH6-Q4-W3.pptxqurter our high choom
ENGLISH6-Q4-W3.pptxqurter our high choom
 
Earth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice greatEarth Day Presentation wow hello nice great
Earth Day Presentation wow hello nice great
 
Gas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptxGas measurement O2,Co2,& ph) 04/2024.pptx
Gas measurement O2,Co2,& ph) 04/2024.pptx
 
How to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERPHow to do quick user assign in kanban in Odoo 17 ERP
How to do quick user assign in kanban in Odoo 17 ERP
 
Judging the Relevance and worth of ideas part 2.pptx
Judging the Relevance  and worth of ideas part 2.pptxJudging the Relevance  and worth of ideas part 2.pptx
Judging the Relevance and worth of ideas part 2.pptx
 
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
USPS® Forced Meter Migration - How to Know if Your Postage Meter Will Soon be...
 
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTSGRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
GRADE 4 - SUMMATIVE TEST QUARTER 4 ALL SUBJECTS
 
Karra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptxKarra SKD Conference Presentation Revised.pptx
Karra SKD Conference Presentation Revised.pptx
 
Keynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-designKeynote by Prof. Wurzer at Nordex about IP-design
Keynote by Prof. Wurzer at Nordex about IP-design
 
OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...OS-operating systems- ch04 (Threads) ...
OS-operating systems- ch04 (Threads) ...
 
What is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERPWhat is Model Inheritance in Odoo 17 ERP
What is Model Inheritance in Odoo 17 ERP
 
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdfAMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
AMERICAN LANGUAGE HUB_Level2_Student'sBook_Answerkey.pdf
 
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdfLike-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
Like-prefer-love -hate+verb+ing & silent letters & citizenship text.pdf
 
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITYISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
ISYU TUNGKOL SA SEKSWLADIDA (ISSUE ABOUT SEXUALITY
 
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATIONTHEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
THEORIES OF ORGANIZATION-PUBLIC ADMINISTRATION
 
Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17Difference Between Search & Browse Methods in Odoo 17
Difference Between Search & Browse Methods in Odoo 17
 

Trials of diet and lifestyle modifications: Food fights and other battles

  • 1. Trials of diet and lifestyle modification: Food fights and other battles Lawrence J. Appel, MD, MPH Professor of Medicine, Epidemiology and International Health (Human Nutrition) Johns Hopkins Medical Institutions Sept 2, 2009
  • 2.
  • 3.
  • 4.  
  • 5.
  • 6.
  • 7.
  • 8. Stroke Mortality by Level of Usual Systolic BP* *Source: Prospective Studies Collaboration, Lancet, 2002: Meta-analysis of 61 prospective studies with 2.7m person-yrs, 11.9k deaths Definition of Hypertension
  • 9. Blood Pressure Classification (JNC VII) Category Systolic BP Diastolic BP Normal < 120 and < 80 Pre-hypertension 120-139 or 80–89 Hypertension Stage 1 Stage 2 140–159 > 160 or or 90–99 > 100
  • 10. Distribution of BP Levels in US Adults, Ages 18 and Older (NHANESIII) “ Normal” <120/80 Prehypertension SBP 120-39 or DBP 80-89 Hypertension SBP > 140 or DBP > 90 Source: Wang, Hypertension, 2004 42% 27% 31%
  • 11. Prevalence of High Blood Pressure by Age and Race/Ethnicity, Women, Age 18 and Older * Extimate is based on sample size not meeting requirement of NHANES III design or relative standard error is greater than 30 percent. 100 30 20 10 0 Percent 40 Black (excludes Hispanic Blacks) 80 70 60 50 90 White (excludes Hispanic Whites) Mexican American 18-29 2.0* 1.0* 0.6* 30-39 11.3 6.2 4.6* 40-49 30.5 10.6 12.7 50-59 47.9 33.5 36.8 60-69 77.8 59.3 50.9 70-79 72.6 67.0 66.9 80 + 80.5* 71.0* 74.3 Source: Burt V, et al. Hypertension, 1995
  • 12. Mean SBP and DBP by Age and Race/Ethnicity for Women, Age 18 Years and Older 150 140 130 120 110 100 90 80 70 mm Hg 18-29 30-39 40-49 50-59 60-69 70-79 80+ Diastolic Systolic Source: Burt V, et al. Hypertension, 1995 SBP Rise with Age = ~0.6 mmHg per year Age Black White Mexican-American
  • 13.
  • 14. Effects of Population-Based BP Reduction (Shifting SBP Distribution Downward) Stamler R. Hypertension 1991;17:I-16–I-20. % Reduction in Mortality Reduction in BP After Intervention Before Intervention Stroke CHD Total -6 -4 -3 -8 -5 -4 -14 -9 -7 Reduction in SBP mmHg 2 3 5
  • 16. Types of Trials Type of Trial Research Question Examples Feeding Studies Effects of Diet Change on Blood Pressure and Other Risk Factors DASH DASH-Na OmniHeart Behavioral Intervention Studies Feasibility and Effects of Lifestyle Change in Free-Living Individuals TOHP1 TOHP2 TONE PREMIER Wt Loss Maintenance
  • 17. D ietary A pproaches to S top H ypertension
  • 18. DASH Centers Hopkins Pennington Brigham NHLBI Duke CHR
  • 19.
  • 20. Run-in and Intervention Periods 3 wks 8 weeks Run-in Intervention Control Diet Control F & V Combination Randomization
  • 21.
  • 22.
  • 23.
  • 25. Weekly BP by Diet During Intervention Feeding WEEKS B 1 2 3 4 5 6 7,8 DIASTOLIC SYSTOLIC Appel, NEJM 1997;336:1117
  • 26. Effect of DASH Diet by BP Status Hypertensives Non-Hypertensives * † * * * * p< 0.05 (main effect) † p< 0.05 (BP status interaction)
  • 27. The DASH diet: Can it be improved?
  • 28.
  • 29. Participant Flow Period 1 6 weeks Period 2 6 weeks Period 3 6 weeks Randomization to 1 of 6 sequences Washout Period 2–4 wk Washout Period 2-4 wk BP, Lipids: Run-In 6 days Participants Ate Study Food Screening / Baseline Participants Ate Their Own Food
  • 30. Macronutrient Goals, % kcal *Similar to DASH diet. All diets were healthy: cholesterol 150 mg/d, fiber 30 g/d, sodium 100 mmol/d, potassium 120 mmol/d, magnesium 500 mg/d, calcium 1,200 mg/d CARB* Carbohydrate 58 Protein 15 Fat 27 Monounsaturated 13 Polyunsaturated 8 Saturated 6
  • 31. Macronutrient Goals, % kcal *Similar to DASH diet. All diets were healthy: cholesterol 150 mg/d, fiber 30 g/d, sodium 100 mmol/d, potassium 120 mmol/d, magnesium 500 mg/d, calcium 1,200 mg/d CARB* PROT Carbohydrate 58 48 Protein 15 25 Fat 27 27 Monounsaturated 13 13 Polyunsaturated 8 8 Saturated 6 6
  • 32. Macronutrient Goals, % kcal *Similar to DASH diet. All diets were healthy: cholesterol 150 mg/d, fiber 30 g/d, sodium 100 mmol/d, potassium 120 mmol/d, magnesium 500 mg/d, calcium 1,200 mg/d CARB* PROT UNSAT Carbohydrate 58 48 48 Protein 15 25 15 Fat 27 27 37 Monounsaturated 13 13 21 Polyunsaturated 8 8 10 Saturated 6 6 6
  • 33. Systolic Blood Pressure CARB* PROT UNSAT CARB* PROT UNSAT All (n = 164) Baseline mean = 131.2 mmHg Hypertension (n = 32) Baseline mean = 146.5 mmHg p = 0.002 -1.4 -1.3 p = 0.005 -2.9 p = 0.02 -3.5 p = 0.006 * CARB similar to DASH diet Appel, JAMA 2005;294:2455
  • 34. LDL Cholesterol CARB* PROT UNSAT CARB* PROT UNSAT All (n = 161) Baseline mean = 129.2 mg/dL LDL ≥ 130 mg/dL (n = 75) Baseline mean = 156.7 mg/dL p = 0.01 -3.3 +1.5 p = 0.24 -1.5 p = 0.22 -2.1 p = 0.33 +1.7 p = 0.45 -3.9 p = 0.09 * CARB similar to DASH diet
  • 35. Effects of Reducing (Substituting) Carbohydate on BP in Hypertensives 1 He, Ann Int Med, 2005; 2 Appel, JAMA, 2005; 3 Hodgson, AJCN, 2006 Partially Substituting Carbohydrate with: Carb (% kcal) Reduction Net SBP Net DBP Soy Protein 1 -3.7% -7.9 -5.3 Mixed Protein 2 -10% -3.5 -2.4 Lean Red Meat 3 -5.3% -5.2 +0.2 Monounsat Fat 2 -10% -2.9 -1.9
  • 37. Key Studies Supporting the Role of Sodium Reduction as a Means to Lower BP Non-Hypertensives Study Reduce BP DASH-Na Prevent hypertension TOHP 2 Prevent age-related rise in BP INTERSALT Prevent CVD events TOHP 3 Hypertensives Initial therapy DASH-Na Adjunct to drug therapy TONE Substitute for medication TONE
  • 39. Percent Reduction in Incident Hypertension over 36-48 Months from Weight Loss and Sodium Reduction Interventions in TOHP2 6 Months 18 Months End of Study * * * * * * * * * P <0.05
  • 40. Control Diet Randomization Run-in: (11-14 days) Intervention (Three 30-day periods, random order) Intermediate Sodium Higher Sodium Lower Sodium Higher Sodium Intermediate Sodium Lower Sodium Study Design Control Diet, N = 204 DASH Diet, N = 208 N = 412
  • 41. Effect of Sodium Level on Systolic Blood Pressure Systolic Blood Pressure Control Diet DASH Diet Higher Intermed Lower Sodium Level (mmol/d) - 6.7 p<.0001 - 3.0 P<.0001 Sacks, NEJM 2001;344:3 (143) (106) (65) - 2.1 - 1.3 - 1.7 - 4.6
  • 42. Systolic Blood Pressure Control Diet DASH Diet Higher Intermed Lower Sodium Level Effect of DASH Diet on Systolic Blood Pressure -2.2 p=.02 -5.0 p=.0003 -5.9 p<0.0001
  • 43. Interactive Effects of Reduced Na and DASH Diet on Systolic BP Systolic Blood Pressure Higher Lower Sodium Level Na Effect in Control Diet = - 6.7 DASH Effect - 5.7 Combined* Effects Actual = - 8.9 Predicted = - 12.4 * P < 0.001, Strict Additivity
  • 44. Effects of Reduced Na on CVD Events: Results from 3 Randomized Trials INTERVENTION OUTCOME FU TONE (2001) 639 Elderly ↓ Na 21% ↓ CVD events 2.3 yrs Taiwan Veterans (2006) 1,981 Elderly ↓ Na /↑ K Salt 41%* ↓ CVD Mortality 2.6 yrs TOHP Follow-up [abs] 3,126 Prehypertensives ↓ Na 30%* ↓ CVD events 10-15 yrs *p<0.05
  • 45. Effects of Reduced Na Intake on CVD: Longterm Results from the Trials of Hypertension Prevention (Cook et al, BMJ, 2007) Adj RR = 0.70 p=0.02
  • 46. Opportunities to Reduce Racial Disparities in BP
  • 47. Effect of Na Reduction (Higher to Lower) in African-Americans and Non-African-Americans on Typical American Diet African-Americans Non-African-Americans - 8.0 † P<.001 - 4.5 † P<.001 - 5.1 P<.001 - 2.2 P<.001 0 † P-interaction < 0.05
  • 48. Effect of DASH Diet By Race African-Americans Non-African-Americans * † * * * * p< 0.05 (main effect) † p< 0.05 (race interaction)
  • 49. Older-aged individuals can make and sustain lifestyle changes that control BP
  • 50. Mean Change in Weight (kg) by Randomized Group in Older-Aged Persons (TONE) 0 9 18 30 Whelton JAMA 1998;279:839.
  • 51. Mean Change in Urinary Sodium Excretion (mmol/24hr) in Older-Aged Persons (TONE) 0 9 18 30 Whelton JAMA 1998;279:839.
  • 52.
  • 53. Design Randomization Primary Outcomes (6 months) End of Intervention (18 months) = Data Visit ADVICE ONLY EST EST + DASH
  • 54. Change in Weight (kg) (Baseline Wt = 97 kg) * * *p<0.001 vs Advice Change in Wt (Kg)
  • 55. Change in Fitness* (Baseline = 130 beats/min) * *p<0.05 vs Advice Change in HR (Beats/min) * Heart Rate (beats/min at Stage 2 of exercise test)
  • 56. Change in Urine Na Excretion (Baseline=170 mmol/24 hr) * * * p < 0.05 vs Advice Change in Urine Na (mmol/24 hr)
  • 57. Fruit and Vegetable Intake (servings/day) * p <.001 EST+ DASH vs Advice + p <.001 EST + DASH vs EST * + Fruit and Veg (serv/day)
  • 58. Saturated Fat Intake (% kcal) ** p <.05 vs Advice * p <.0001 vs Advice + p <.0001 EST+DASH vs EST * + ** Sat Fat Intake (%kcal)
  • 59. Hypertension Prevalence (Among Those with Hypertension at Baseline) + p <.01 vs Advice % with Hypertension + + + +
  • 60. 10-Year Probability of CHD Event RR = 0.89 (0.84-0.94), P <0.001 RR = 0.87 (0.82-0.92), P <0.001
  • 61. 2005 Dietary Guidelines for Americans JNC VII – Hypertension Prevention and Treatment Guidelines 2006 American Heart Association Guidelines
  • 63.
  • 64. Design Self-Directed (SD) – comparison group Call-Center Directed (CCD) In-Person Directed (IPD) Randomization Last visits: 24 – 36 m after randomization = Data Collection Points, every 6 months during follow-up
  • 65. Description of Groups Randomized Groups Self-Directed (SD) Call-Center Directed (CCD) In-Person Directed (IPD) Counselor: None Healthways Coach Hopkins Coach Static Website: √ Interactive Web-site: √ √ Sessions: Telephone Only Group Mtgs Individual Telephone PCP Reinforcement √ √
  • 66. CCD and IPD Intervention Goals Weight Goal Minimum 5% weight loss, individually tailored Behaviors Calories 1200 kcal/d if ≤ 170 lb; 1500 kcal/d if > 170 lb and < 220 lb; 1800 kcal/d if > 220 lb and < 270 lb; 2200 kcal/d if > 270 lb Diet DASH diet 7-12 services of fruits/vegetables 2-3 servings of low fat dairy low sodium ≤ 25% of calories from fat Exercise Build to ≥ 180 minutes/wk of moderate intensity physical activity in bouts ≥ 10 minutes in length
  • 67.
  • 68.
  • 69.
  • 70. Lessons and Battles (Food Fights)
  • 71.
  • 72.
  • 73.
  • 74.
  • 75.
  • 76.
  • 77.
  • 78. Costs of Lifestyle Intervention Trials Sample Size Duration of Intervention Total Costs Per Participant Costs POWER 415 2 yr $5.9 m $14.2k
  • 79. Costs of Feeding Studies Sample Size Duration of Feeding Total Costs Per Participant Costs DASH 459 11wk $7.8 m $17k DASH-Sodium 412 14 wk $11.8 m $29k Omni Heart 160 19 wk $6.2 m $39k Omni Carb 160 21 wk $10.3 m $64k
  • 80. Costs of Mass Mailing in Feeding Studies DASH DASH-Sodium OmniHeart # Brochures Sent 115,000 265,000 393,000 # Enrolled from Mass Mailing 90 69 72 Yield/ 10k Brochures 7.8 2.6 1.8 Mailing Costs Per Enrolled $486 $1,459 $2,074 Total Mailing Costs $43,700 $100,700 $149,340
  • 81.
  • 82.
  • 83.  
  • 84.  
  • 85.  
  • 86.  
  • 87.  
  • 88.
  • 89.
  • 90. MI, CHD Death, or Revascularization (all participants) Stroke Effects of WHI Dietary Modification Intervention on Total CVD and Stroke Time, y HR, 0.97 (95% CI, 0.90-1.06) Comparison Intervention Time, y HR,1.02 (95% CI, 0.90-1.15) Comparison Intervention
  • 91. Comparison of Lipids, Blood Pressure, and Framingham Risk Score Effects of WHI Diet and OMNI-Heart* Diets *OMNI-Heart = Optimal Macronutrient Intake Trial to Prevent Heart Disease Source: Appel LJ, et al. JAMA 2005; 294:2455-64 OMNI-Heart WHI Carb Protein Unsat Fat (yr 3) Total Chol (mg/dl) -3.3 -12.4 -19.9 -15.4 LDL-C -3.6 -11.6 -14.2 -13.1 HDL-C -0.4 -1.4 -2.6 -0.3 Triglycerides 0 0.1 -16.4 -9.3 SBP (mmHg) -0.2 -8.2 -9.5 -9.3 DBP (mmHg) -0.3 -4.1 -5.2 -4.8 Framingham Estimated 10-Yr Risk  3-4%  16%  21%  20%
  • 92.
  • 93.

Notas del editor

  1. SLIDE 5 These are the centers that were involved in DASH. The Center for Health Research in Portland, Oregon was our coordinating center. The NHLBI, although they did not recruit subjects, served as a full partner in all of the study planning. The four clinical centers which were involved in recruiting and studying subjects were the Brigham and Woman’s Hospital in Boston, Johns Hopkins University in Baltimore, Duke in Durham and the Pennington Center in Baton Rouge, Louisiana. 3:18
  2. SLIDE 3 So the goal of DASH was to identify a dietary pattern that captures and reproduces the blood pressure lowering effect of a vegetarian diet but which contains enough meat and other food products to be palatable and acceptable to the general population.
  3. SLIDE 7 This is a diagrammatic presentation of the 11 week feeding period. Not shown on this slide, there were three screening visits to assure that blood pressure was in the proper range and that there were no important concomitant medical conditions. Subjects who passed the screening visits entered the run-in phase of feeding. Run-in was a three week period of time when all subjects received our control diet. At the end of run-in, subjects were randomized to one of three diets for the next eight weeks: either a continuation of the CONTROL diet, a diet high in fruits and vegetables, or our combination diet. During this entire 11 weeks, subjects ate their main meal of the day Monday through Friday in the Clinic site dining area. On Friday, they received their food for Saturday and Sunday, which they ate on their own at home over the weekend. To monitor urinary electrolyte excretion, we collected a 24 hour urine sample at the end of the run-in phase and at the end of the intervention diet. The change in blood pressure from the beginning to end of the 8 weeks’ intervention feeding was our endpoint.
  4. SLIDE 12 We randomized 459 subjects, equally divided between men and women. 60% of subjects were minorities, with 90% of those being African-American. Average age was 45 years. The Pre-study BP for the overall group was 132/85, and 29% of subjects had hypertension, defined as sys &gt;140 and/or dias &gt;90. On average, the subjects were modestly overweight: the body mass index was 28.7 for women and 27.7 for men.
  5. IOM Recommendations: 45-65% Carb 20-35% fat 10-35% protein **The rest of the nutrient profile is the same between the diets
  6. IOM Recommendations: 45-65% Carb 20-35% fat 10-35% protein **The rest of the nutrient profile is the same between the diets
  7. IOM Recommendations: 45-65% Carb 20-35% fat 10-35% protein **The rest of the nutrient profile is the same between the diets
  8. Source: TK4061903
  9. Figure 2b
  10. Figure 2b
  11. Figure 2b
  12. HOPKINS POWER TRIAL
  13. Need to confirm Omni $
  14. Need to confirm Omni $
  15. Need to confirm Omni $
  16. Need to confirm Omni $
  17. Need to confirm Omni $